CD177 and Hyperglycemia: Hyperglycemia-induced oxidative stress and inflammation unleash a cascade of events that affect cellular proteins, gene expression, and cell surface receptor expression, ultimately resulting in progressive pathologic changes in diabetic kidneys [4].